Anita Sveen

5.1k total citations · 1 hit paper
61 papers, 3.0k citations indexed

About

Anita Sveen is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Anita Sveen has authored 61 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cancer Research, 30 papers in Oncology and 28 papers in Pathology and Forensic Medicine. Recurrent topics in Anita Sveen's work include Genetic factors in colorectal cancer (27 papers), Colorectal Cancer Treatments and Studies (25 papers) and Cancer Genomics and Diagnostics (22 papers). Anita Sveen is often cited by papers focused on Genetic factors in colorectal cancer (27 papers), Colorectal Cancer Treatments and Studies (25 papers) and Cancer Genomics and Diagnostics (22 papers). Anita Sveen collaborates with scholars based in Norway, United States and United Kingdom. Anita Sveen's co-authors include Ragnhild A. Lothe, Rolf I. Skotheim, Arild Nesbakken, Jarle Bruun, Peter W. Eide, Scott Kopetz, Ina A. Eilertsen, Anja Ruusulehto, Sami Kilpinen and Stine A. Danielsen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Anita Sveen

59 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biomarker-guided therapy for colorectal cancer: strength in complexity

2019 235 citations Anita Sveen, Ragnhild A. Lothe et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anita Sveen Norway	26	1.5k	1.3k	968	729	539	61	3.0k
Maguy Del Rio France	27	2.0k 1.3×	1.8k 1.3×	1.7k 1.7×	874 1.2×	717 1.3×	56	3.8k
Marian Grade Germany	31	1.5k 1.0×	1.4k 1.1×	879 0.9×	570 0.8×	444 0.8×	85	3.0k
Sichuan Xi United States	32	2.0k 1.3×	1.4k 1.1×	754 0.8×	296 0.4×	568 1.1×	55	3.2k
Paola Parrella Italy	29	2.3k 1.5×	773 0.6×	1.1k 1.1×	368 0.5×	363 0.7×	79	3.3k
Cátia Moutinho Spain	27	2.2k 1.4×	816 0.6×	1.2k 1.2×	481 0.7×	291 0.5×	35	3.0k
Melissa J. LaBonte United States	27	1.2k 0.8×	1.3k 1.0×	526 0.5×	287 0.4×	393 0.7×	78	2.6k
Abdul K. Siraj Saudi Arabia	29	1.5k 1.0×	812 0.6×	577 0.6×	623 0.9×	278 0.5×	121	2.7k
Linda Mora United States	15	1.3k 0.8×	1.6k 1.2×	473 0.5×	498 0.7×	314 0.6×	29	2.6k
Miriam Martini Italy	24	2.1k 1.4×	2.4k 1.8×	971 1.0×	1.1k 1.5×	1.0k 1.9×	45	4.5k
Roberta Pang Hong Kong	29	1.6k 1.0×	1.1k 0.8×	987 1.0×	383 0.5×	288 0.5×	53	3.0k

Countries citing papers authored by Anita Sveen

Since Specialization

Citations

This map shows the geographic impact of Anita Sveen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anita Sveen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anita Sveen more than expected).

Fields of papers citing papers by Anita Sveen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anita Sveen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anita Sveen. The network helps show where Anita Sveen may publish in the future.

Co-authorship network of co-authors of Anita Sveen

This figure shows the co-authorship network connecting the top 25 collaborators of Anita Sveen. A scholar is included among the top collaborators of Anita Sveen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anita Sveen. Anita Sveen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bergsland, Christian H., Anita Sveen, Jarle Bruun, et al.. (2024). The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration. Cellular Oncology. 47(4). 1267–1276. 6 indexed citations

Sveen, Anita, Bjarne Johannessen, Sigrid Marie Kraggerud, et al.. (2024). Evolutionary mode and timing of dissemination of high-grade serous carcinomas. JCI Insight. 9(3). 1 indexed citations

Høland, Maren, Kaja C. G. Berg, Ina A. Eilertsen, et al.. (2023). Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets. EBioMedicine. 97. 104829–104829. 10 indexed citations

Vedeld, Hege Marie, Rita Pinto, Guro E. Lind, et al.. (2020). Multiregional assessment of CIMP in primary colorectal cancers: Phenotype concordance but marker variability. International Journal of Cancer. 148(7). 1652–1657. 5 indexed citations

Bergsland, Christian H., Jarle Bruun, Marianne G. Guren, et al.. (2020). Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer. ESMO Open. 5(6). e001040–e001040. 6 indexed citations

Berg, Kaja C. G., Anita Sveen, Sharmini Alagaratnam, et al.. (2020). Genomic and prognostic heterogeneity among RAS/BRAF^V600E/TP53 co‐mutated resectable colorectal liver metastases. Molecular Oncology. 15(4). 830–845. 11 indexed citations

Sveen, Anita, Bjørn Atle Bjørnbeth, Bård I. Røsok, et al.. (2019). High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases. Clinical Colorectal Cancer. 19(1). e26–e47. 17 indexed citations

Dienstmann, Rodrigo, Guillermo Villacampa, Anita Sveen, et al.. (2019). Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer. Annals of Oncology. 30(10). 1622–1629. 149 indexed citations

Sveen, Anita, Christian H. Bergsland, Ina A. Eilertsen, et al.. (2019). Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer. ESMO Open. 4(3). e000523–e000523. 13 indexed citations

10.

Sveen, Anita, Marianne A. Merok, Stine A. Danielsen, et al.. (2018). CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer. Annals of Oncology. 29(5). 1227–1234. 63 indexed citations

11.

Sveen, Anita, Jarle Bruun, Peter W. Eide, et al.. (2017). Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies. Clinical Cancer Research. 24(4). 794–806. 173 indexed citations

12.

Sveen, Anita, Christian H. Bergsland, Marianne A. Merok, et al.. (2017). Prognostic impact of BRAF and KRAS mutations according to the consensus molecular subtypes of colorectal cancer. Annals of Oncology. 28. v186–v186.

13.

Sveen, Anita, Inger Marie Løes, Sharmini Alagaratnam, et al.. (2016). Intra-individual genetic heterogeneity among liver metastases in metastatic colorectal cancer.. Journal of Clinical Oncology. 34(4_suppl). 555–555. 1 indexed citations

14.

Johannessen, Bjarne, Anita Sveen, & Rolf I. Skotheim. (2015). TIN: An R Package for Transcriptome Instability Analysis. Cancer Informatics. 14. CIN.S31363–CIN.S31363. 3 indexed citations

15.

Sveen, Anita, Trude H. Ågesen, Arild Nesbakken, et al.. (2012). ColoGuidePro: A Prognostic 7-Gene Expression Signature for Stage III Colorectal Cancer Patients. Clinical Cancer Research. 18(21). 6001–6010. 100 indexed citations

16.

Alagaratnam, Sharmini, Neil A. Harrison, Anne Cathrine Bakken, et al.. (2012). Transforming Pluripotency: An Exon-Level Study of Malignancy-Specific Transcripts in Human Embryonal Carcinoma and Embryonic Stem Cells. Stem Cells and Development. 22(7). 1136–1146. 11 indexed citations

17.

Sveen, Anita, Trude H. Ågesen, Arild Nesbakken, et al.. (2011). Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival. Genome Medicine. 3(5). 32–32. 70 indexed citations

18.

Mathiesen, Geir, Anita Sveen, May Bente Brurberg, et al.. (2009). Genome-wide analysis of signal peptide functionality in Lactobacillus plantarum WCFS1. BMC Genomics. 10(1). 425–425. 88 indexed citations

19.

Mathiesen, Geir, Anita Sveen, Jean-Christophe Piard, Lars Axelsson, & Vincent G. H. Eijsink. (2008). Heterologous protein secretion byLactobacillus plantarumusing homologous signal peptides. Journal of Applied Microbiology. 105(1). 215–226. 60 indexed citations

20.

Dahl, Vegard, et al.. (2002). High-dose diclofenac for postoperative analgesia after elective caesarean section in regional anaesthesia. International Journal of Obstetric Anesthesia. 11(2). 91–94. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact